Abstract:BACKGROUND Major depressive disorder (MDD) is a common and serious mental illness. Many novel genes in MDD have been characterized by high-throughput methods such as microarrays or sequencing. Recently, noncoding RNAs (ncRNAs) were suggested to be involved in the complicated environmental-genetic regulatory network of MDD occurrence; however, the interplay among RNA species, including protein-coding RNAs and ncRNAs, in MDD remains unclear. AIM To investigate the RNA expression datasets downloaded from a public database and construct a network based on differentially expressed long noncoding RNA (lncRNAs), microRNAs (miRNAs), and mRNAs between MDD and controls. METHODS Gene expression data were searched in NCBI Gene Expression Omnibus using the search term “major depressive disorder.” Six array datasets from humans were related to the search term: GSE19738, GSE32280, GSE38206, GSE52790, GSE76826, and GSE81152. These datasets were processed for initial assessment and subjected to quality control and differential expression analysis. Differentially expressed lncRNAs, miRNAs, and mRNAs were determined, Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses were performed, and protein-protein interaction network was generated. The results were analyzed for their association with MDD. RESULTS After analysis, 3 miRNAs, 12 lncRNAs, and 33 mRNAs were identified in the competing endogenous RNA network. Two of these miRNAs were earlier shown to be involved in psychiatric disorders, and differentially expressed mRNAs were found to be highly enriched in pathways related to neurogenesis and neuroplasticity as per Gene Ontology and Kyoto Encyclopedia of Genes and Genomes enrichment analyses. The expression of hub gene fatty acid 2-hydroxylase was enriched, and the encoded protein was found to be involved in myelin formation, indicating that neurological development and signal transduction are involved in MDD pathogenesis. CONCLUSION The present study presents candidate ncRNAs involved in the neurogenesis and neuroplasticity pathways related to MDD.

Pathogenetic and therapeutic roles of non-coding RNAs on major depressive disorder

The Link Between Long Noncoding RNAs and Depression.

Non-coding RNAs in Depression: Promising Diagnostic and Therapeutic Biomarkers

A new perspective on depression and neuroinflammation: Non-coding RNA

Identification and Characterization of Noncoding RNAs-associated Competing Endogenous RNA Networks in Major Depressive Disorder

Mutual regulation of noncoding RNAs and RNA modifications in psychopathology: Potential therapeutic targets for psychiatric disorders?

Molecular, Functional, and Structural Imaging of Major Depressive Disorder

Emerging roles of long non-coding RNA in depression

Prospective Role of MicroRNAs in Depression

The role of microRNAs in depression

The emerging role of long noncoding RNA in depression and its implications in diagnostics and therapeutic responses

Microarray Analysis of the Major Depressive Disorder Mrna Profile Data.

A New Player in Depression: MiRNAs as Modulators of Altered Synaptic Plasticity

Non-Coding RNAs in Neurological and Neuropsychiatric Disorders: Unraveling the Hidden Players in Disease Pathogenesis

The roles of extracellular vesicles in major depressive disorder

Major Depressive Disorder: Advances in Neuroscience Research and Translational Applications

Bridging Molecular Discoveries and Therapeutic Potential

Advances in biosensors for major depressive disorder diagnostic biomarkers

Epigenetic regulation in major depression and other stress-related disorders: molecular mechanisms, clinical relevance and therapeutic potential

RNA methylations in depression, from pathological mechanism to therapeutic potential

Prefrontal cortex astrocytes in major depressive disorder: exploring pathogenic mechanisms and potential therapeutic targets